Tiny robots swimming along the bloodstream to diagnose our medical condition could soon be a reality. Australian scientists have developed a new twisting artificial muscle to propel the nanobots. The research has been published in the journal Science.
Although Nanorobots (Nanobots) have received much attention for the potential medical use in the body, such as cancer fighting, drug delivery and parasite removal, one major hurdle in their development has been the issue of how to propel them along in the bloodstream.
AdvertisementAn international collaborative team led by researchers at University of Wollongong has developed the new twisting muscle that could do the job.
The Wollongong scientists are attached to the Intelligent Polymer Research Institute (IPRI), part of the ARC Centre of Excellence for Electromaterials Science (ACES),
The muscles use very tough and highly flexible yarns of carbon nanotubes (nanoscale cylinders of carbon), which are twist-spun into the required form. When voltage is applied, the yarns rotate up to 600 revolutions a minute, then rotate in reverse when the voltage is changed.
Due to their complexity, conventional motors are very difficult to miniaturise, making them unsuitable for use in nanorobotics.
"The twisting artificial muscles, on the other hand, are simple and inexpensive to construct either in very long, or in millimetre lengths," according to ACES Chief Investigator, Professor Geoff Spinks.
"This new, giant, rotating type of actuation will open up lots of new opportunities for micro-machines," he said.
Professor Spinks said the tiny artificial muscles can twist like those in the trunk of an elephant or the arm of an octopus.
"In these appendages, helically wound muscle fibres rotate by contracting against an incompressible, bone-less core. The rotation in the helically wound carbon nanotubes used for the twisting artificial muscles is caused by an increase of liquid electrolyte volume within the yarn, Professor Spinks said.
The research team working on this project includes Professor Spinks, Dr Javad Foroughi (Research Fellow with IPRI) and Professor Gordon Wallace (IPRI Director and the Executive Research Director of ACES). It also involves researchers from the University of Texas, Hanyang University and the University of British Columbia.
Professor Wallace said the exciting breakthrough has been made possible through the tremendous efforts of a team of multidisciplinary researchers working from four different countries over a sustained period of time.
"ACES continues to attract important collaborative research linkages with leading groups around the world and this is critical to maintain our position at the leading edge of scientific research," Professor Wallace said.
P Psychological Support First, Hearing Aids Next, Says Expert IVF Treatment Linked to Ovarian Cancer Risk M
You May Also Like